Cargando…

Prevention, Intervention and Care of Neurodegenerative Diseases

Detalles Bibliográficos
Autores principales:	Bakirtzis, Christos, Boziki, Marina-Kleopatra, Grigoriadis, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454199/ https://www.ncbi.nlm.nih.gov/pubmed/37628546 http://dx.doi.org/10.3390/healthcare11162349

Ejemplares similares

Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis
por: Chalkias, Ioannis-Nikolaos, et al.
Publicado: (2022)

The Role of Diet and Interventions on Multiple Sclerosis: A Review
por: Stoiloudis, Panagiotis, et al.
Publicado: (2022)

Smell as a Disease Marker in Multiple Sclerosis
por: Printza, Athanasia, et al.
Publicado: (2022)

CNS Ageing in Health and Neurodegenerative Disorders
por: Kesidou, Evangelia, et al.
Publicado: (2023)

A Greek Validation Study of the Multiple Sclerosis Work Difficulties Questionnaire-23
por: Bakirtzis, Christos, et al.
Publicado: (2021)

COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Oxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases
por: Gkekas, Ioannis, et al.
Publicado: (2021)

The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
por: Barmpagiannos, Konstantinos, et al.
Publicado: (2023)

The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database
por: Bakirtzis, Christos, et al.
Publicado: (2020)

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center
por: Boziki, Marina, et al.
Publicado: (2021)

Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis
por: Boziki, Marina, et al.
Publicado: (2022)

Biomarkers in Rare Demyelinating Disease of the Central Nervous System
por: Boziki, Marina, et al.
Publicado: (2020)

Editorial: Complement in nervous system disease
por: Michailidou, Iliana, et al.
Publicado: (2023)

A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination
por: Boziki, Marina, et al.
Publicado: (2021)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Imaging Neurodegenerative Diseases: Mechanisms and Interventions
por: Bai, Lijun, et al.
Publicado: (2014)

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases
por: Sintila, Styliani-Aggeliki, et al.
Publicado: (2023)

Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
por: Boziki, Marina, et al.
Publicado: (2022)

The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians
por: Bakirtzis, Christos, et al.
Publicado: (2018)

Pain Assessment in Neurodegenerative Diseases
por: de Tommaso, Marina, et al.
Publicado: (2016)

Signaling through the S1P−S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment
por: Chatzikonstantinou, Simela, et al.
Publicado: (2021)

Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial
por: Messinis, Lambros, et al.
Publicado: (2017)

Advances in Neurodegenerative Diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2023)

Lipids in Neurodegenerative Diseases
por: Chiurchiù, Valerio
Publicado: (2023)

Mitochondria in neurodegenerative diseases
por: Lin, Fang, et al.
Publicado: (2019)

Biomarkers in Neurodegenerative Diseases
por: Ghosh, Arnab
Publicado: (2022)

Advances in Neurodegenerative Diseases
por: Siokas, Vasileios, et al.
Publicado: (2022)

Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2021)

Estimating Everyday Neuropsychological Functioning in Multiple Sclerosis: Reliability and Validity of the Greek Multiple Sclerosis Neuropsychological Questionnaire
por: Konstantinopoulou, Eleni, et al.
Publicado: (2018)

Protein Kinases and Neurodegenerative Diseases
por: Kawahata, Ichiro, et al.
Publicado: (2023)

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

Protein Misfolding and Neurodegenerative Diseases
por: Cardinale, Alessio, et al.
Publicado: (2014)

Multitarget Therapeutics for Neurodegenerative Diseases
por: Gabr, Moustafa T., et al.
Publicado: (2020)

Neuroplasticity in the Pathology of Neurodegenerative Diseases
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Biochemical Biomarkers and Neurodegenerative Diseases
por: Ciaccio, Marcello
Publicado: (2021)

Oxidative Stress in Neurodegenerative Diseases
por: Domanskyi, Andrii, et al.
Publicado: (2022)

Marijuana's potential in neurodegenerative diseases: an editorial
por: Arachchige, Arosh S. Perera Molligoda
Publicado: (2023)

Neurodegenerative Diseases: Molecular Mechanisms and Therapies
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b6rhc3b7nb1nrbgrhicum0pl3f